- Home
- CRI vs CLDX Comparison
CRI vs CLDX Comparison
Compare CRI & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRI
- CLDX
- Stock Information
- Founded
- CRI 1865
- CLDX N/A
- Country
- CRI United States
- CLDX United States
- Employees
- CRI N/A
- CLDX N/A
- Industry
- CRI Apparel
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CRI Consumer Discretionary
- CLDX Health Care
- Exchange
- CRI Nasdaq
- CLDX Nasdaq
- Market Cap
- CRI 1.2B
- CLDX 1.3B
- IPO Year
- CRI 2003
- CLDX 2008
- Fundamental
- Price
- CRI $32.16
- CLDX $22.11
- Analyst Decision
- CRI Sell
- CLDX Buy
- Analyst Count
- CRI 5
- CLDX 9
- Target Price
- CRI $36.80
- CLDX $50.00
- AVG Volume (30 Days)
- CRI 1.6M
- CLDX 1.1M
- Earning Date
- CRI 07-25-2025
- CLDX 08-07-2025
- Dividend Yield
- CRI 10.05%
- CLDX N/A
- EPS Growth
- CRI N/A
- CLDX N/A
- EPS
- CRI 4.51
- CLDX N/A
- Revenue
- CRI $2,812,437,000.00
- CLDX $7,559,000.00
- Revenue This Year
- CRI N/A
- CLDX N/A
- Revenue Next Year
- CRI N/A
- CLDX N/A
- P/E Ratio
- CRI $7.06
- CLDX N/A
- Revenue Growth
- CRI N/A
- CLDX 24.49
- 52 Week Low
- CRI $29.36
- CLDX $14.40
- 52 Week High
- CRI $71.99
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- CRI 52.27
- CLDX 60.12
- Support Level
- CRI $29.61
- CLDX $19.52
- Resistance Level
- CRI $33.06
- CLDX $22.11
- Average True Range (ATR)
- CRI 1.25
- CLDX 1.50
- MACD
- CRI 0.25
- CLDX 0.06
- Stochastic Oscillator
- CRI 75.68
- CLDX 57.43
About CRI Carter's Inc.
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.